DENTSPLY SIRONA, Inc. (XRAY)

Over the past six months, Dentsply Sirona's stock has experienced several notable events and fluctuations. Key events impacting the stock include the Q4 CY2025 earnings report where revenue beat estimates but profit and guidance fell short. The Q3 2025 earnings report showed disappointing results, leading to a stock drop. The Q2 2025 earnings report showed a year-over-year revenue decline. An analyst at Barrington Research maintained an "Outperform" rating on the stock. Dentsply Sirona and Siemens Healthineers announced the FDA clearance of a dental-dedicated MRI system.

Demand for Dentsply Sirona's products and services can exhibit some seasonality and regional variations. The demand for CAD/CAM equipment has softened in the U.S., while professional aligner sales have been growing, especially in Europe. The Essential Dental Solutions segment resonates well with consumers, particularly outside the U.S. and Europe. There is also increased demand for products like Omni One and Omni One Core around the holiday season.

Dentsply Sirona, Inc. is a global leader in professional dental solutions, operating within the healthcare sector. The company develops, manufactures, and markets a comprehensive portfolio of dental equipment, technologies, and consumable products. Its major products and solutions are organized across four main business segments: Connected Technology Solutions provides the digital infrastructure for modern dentistry. Essential Dental Solutions focuses on everyday dental consumables. Orthodontic and Implant Solutions offers dental implant systems, digital dentures, and clear aligner solutions. Wellspect Healthcare provides continence care solutions for urinary and bowel management.

Dentsply Sirona maintains a significant global presence, distributing its products in over 120 to 150 countries. The company's headquarters are in Charlotte, North Carolina, U.S., and it has factories in 21 countries. Key markets include Europe, North America, Asia Pacific, Central and South America, and the Middle East.

Dentsply Sirona has continued to focus on innovation and strategic partnerships, which generally contribute positively to its brand reputation. The FDA clearance of the first-ever dental-dedicated MRI system could enhance its reputation. The company also invests heavily in clinical education, operating 57 academies and education centers across 35 countries.

Dentsply Sirona's stock ownership is primarily held by institutional investors, with approximately 74.57% to 97.40% of the company's stock being institutionally owned. Insiders hold about 0.66% to 2.68%, and public companies and individual investors own around 5.04% to 19.73%. Major institutional owners include Vanguard Group Inc. and BlackRock, Inc.